Acute heart failure after non-cardiac surgery: incidence, phenotypes, determinants and outcomes
Carregando...
Citações na Scopus
7
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
PUELACHER, Christian
CHEW, Michelle S. S.
ANDERSSON, Henrik
BUSE, Giovanna Lurati
GLARNER, Noemi
MUELLER, Daria
BURRI-WINKLER, Katrin
MORK, Constantin
Citação
EUROPEAN JOURNAL OF HEART FAILURE, v.25, n.3, p.347-357, 2023
Resumo
Aims Primary acute heart failure (AHF) is a common cause of hospitalization. AHF may also develop postoperatively (pAHF). The aim of this study was to assess the incidence, phenotypes, determinants and outcomes of pAHF following non-cardiac surgery.Methods and results A total of 9164 consecutive high-risk patients undergoing 11 262 non-cardiac inpatient surgeries were prospectively included. The incidence, phenotypes, determinants and outcome of pAHF, centrally adjudicated by independent cardiologists, were determined. The incidence of pAHF was 2.5% (95% confidence interval [CI] 2.2-2.8%); 51% of pAHF occurred in patients without known heart failure (de novo pAHF), and 49% in patients with chronic heart failure. Among patients with chronic heart failure, 10% developed pAHF, and among patients without a history of heart failure, 1.5% developed pAHF. Chronic heart failure, diabetes, urgent/emergent surgery, atrial fibrillation, cardiac troponin elevations above the 99th percentile, chronic obstructive pulmonary disease, anaemia, peripheral artery disease, coronary artery disease, and age, were independent predictors of pAHF in the logistic regression model. Patients with pAHF had significantly higher all-cause mortality (44% vs. 11%, p < 0.001) and AHF readmission (15% vs. 2%, p < 0.001) within 1 year than patients without pAHF. After Cox regression analysis, pAHF was an independent predictor of all-cause mortality (adjusted hazard ratio [aHR] 1.7 [95% CI 1.3-2.2]; p < 0.001) and AHF readmission (aHR 2.3 [95% CI 1.5-3.7]; p < 0.001). Findings were confirmed in an external validation cohort using a prospective multicentre cohort of 1250 patients (incidence of pAHF 2.4% [95% CI 1.6-3.3%]).Conclusions Postoperative AHF frequently developed following non-cardiac surgery, being de novo in half of cases, and associated with a very high mortality.
Palavras-chave
Acute heart failure, Heart failure, Non-cardiac surgery, Postoperative
Referências
- Andersson C, 2014, EUR J HEART FAIL, V16, P1310, DOI 10.1002/ejhf.182
- Anker SD, 2021, NEW ENGL J MED, V385, P1451, DOI 10.1056/NEJMoa2107038
- Bhatt DL, 2021, NEW ENGL J MED, V384, P129, DOI 10.1056/NEJMoa2030186
- Bueno H, 2022, FRONT CARDIOVASC MED, V9, DOI 10.3389/fcvm.2022.818525
- Chew MS, 2022, BRIT J ANAESTH, V128, P26, DOI 10.1016/j.bja.2021.10.006
- Chioncel O, 2017, EUR J HEART FAIL, V19, P1242, DOI 10.1002/ejhf.890
- Crespo-Leiro MG, 2016, EUR J HEART FAIL, V18, P613, DOI 10.1002/ejhf.566
- Devereaux PJ, 2017, JAMA-J AM MED ASSOC, V317, P1642, DOI 10.1001/jama.2017.4360
- Faxen UL, 2020, J CARD FAIL, V26, P1034, DOI 10.1016/j.cardfail.2020.06.015
- Felker GM, 2011, NEW ENGL J MED, V364, P797, DOI 10.1056/NEJMoa1005419
- Gonzalez-Pacheco H, 2021, ESC HEART FAIL, V8, P423, DOI 10.1002/ehf2.13092
- Gualandro DM, 2017, ARQ BRAS CARDIOL, V109
- Gualandro DM, 2021, CLIN RES CARDIOL, V110, P1450, DOI 10.1007/s00392-021-01827-w
- Gualandro DM, 2017, J VASC SURG, V66, P1826, DOI 10.1016/j.jvs.2017.05.100
- Halvorsen S, 2022, EUR HEART J, V43, P3826, DOI 10.1093/eurheartj/ehac270
- Huang YYC, 2022, ANN SURG, V275, P807, DOI 10.1097/SLA.0000000000004044
- Jackson SL, 2018, CIRC-HEART FAIL, V11, DOI 10.1161/CIRCHEARTFAILURE.117.004873
- Kaspar M, 2018, CLIN RES CARDIOL, V107, P778, DOI 10.1007/s00392-018-1245-z
- Kozhuharov N, 2019, JAMA-J AM MED ASSOC, V322, P2292, DOI 10.1001/jama.2019.18598
- Kristensen SD, 2014, EUR HEART J, V35, P2383, DOI 10.1093/eurheartj/ehu282
- Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043
- Legrand M, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3247-1
- Lerman BJ, 2019, JAMA-J AM MED ASSOC, V321, P572, DOI 10.1001/jama.2019.0156
- Liu ZJ, 2020, CLIN INTERV AGING, V15, P1181, DOI 10.2147/CIA.S252160
- Llorens P, 2018, CLIN RES CARDIOL, V107, P897, DOI 10.1007/s00392-018-1261-z
- Martin-Sanchez FJ, 2016, INT J CARDIOL, V222, P62, DOI 10.1016/j.ijcard.2016.07.151
- Masip J, 2018, EUR HEART J, V39, P17, DOI 10.1093/eurheartj/ehx580
- McDonagh TA, 2022, EUR J HEART FAIL, V24, P4, DOI 10.1002/ejhf.2333
- McMurray JJV, 2019, NEW ENGL J MED, V381, P1995, DOI 10.1056/NEJMoa1911303
- McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077
- Mueller C, 2004, NEW ENGL J MED, V350, P647, DOI 10.1056/NEJMoa031681
- Mueller C, 2017, EUR HEART J-ACUTE CA, V6, P81, DOI 10.1177/2048872615593279
- Pearse RM, 2012, LANCET, V380, P1059, DOI 10.1016/S0140-6736(12)61148-9
- Platz E, 2019, EUR J HEART FAIL, V21, P844, DOI 10.1002/ejhf.1499
- Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
- Puelacher C, 2020, J AM COLL CARDIOL, V76, P1910, DOI 10.1016/j.jacc.2020.08.043
- Puelacher C, 2018, CIRCULATION, V137, P1221, DOI 10.1161/CIRCULATIONAHA.117.030114
- Reis PV, 2019, SEMIN CARDIOTHORAC V, V23, P293, DOI 10.1177/1089253218825442
- Roshanov PS, 2021, CAN J CARDIOL, V37, P1215, DOI 10.1016/j.cjca.2021.03.015
- Sabate S, 2011, BRIT J ANAESTH, V107, P879, DOI 10.1093/bja/aer268
- Shaydenfish D, 2020, ANESTH ANALG, V130, P685, DOI 10.1213/ANE.0000000000004099
- Smilowitz NR, 2021, EUR HEART J-QUAL CAR, V7, P68, DOI 10.1093/ehjqcco/qcz066
- Solomon SD, 2019, NEW ENGL J MED, V381, P1609, DOI 10.1056/NEJMoa1908655
- Velazquez EJ, 2019, NEW ENGL J MED, V380, P539, DOI 10.1056/NEJMoa1812851
- Weber M, 2013, EUR HEART J, V34, P853, DOI 10.1093/eurheartj/ehs445
- Weiser TG, 2015, LANCET, V385, P11, DOI 10.1016/S0140-6736(15)60806-6
- Widimsky P, 2014, NETH HEART J, V22, P372, DOI 10.1007/s12471-014-0575-3
- Wussler D., 2020, SWISS MED WKLY, V150
- Yu PC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010607